On April 7, 2025, the results of the "First Forbes China Investment Value Startup 100 Series Selection" jointly initiated by Forbes China and Wesden were officially announced. Polyseq Biotechnology was honored to be included in the list due to its innovative achievements and huge development potential in the field of sequencing technology.
The purpose of this selection activity is to discover more outstanding start-up companies with growth potential and investment value. Through multiple channels such as independent application by enterprises and recommendation by investment institutions, candidate companies are widely solicited. A combination of evaluation materials review, online roadshows, and offline research is used to comprehensively evaluate the company's revenue scale and growth rate, financing ability, proportion of R&D expenses, number of intellectual property rights (excluding trademarks), and titles and awards already won. Finally, 100 start-up companies with both innovation strength and high growth potential are selected.
Polyseq Biotechnology focuses on the forefront of sequencing technology and is committed to the research and commercialization of proprietary nanopore gene sequencing systems, aiming to promote the development and application of gene sequencing. The company deeply cultivates the research and innovation of underlying technologies, constantly launching innovative and competitive products and technologies. Polyseq Biotechnology has demonstrated outstanding performance in technological innovation, business models, market potential, and team capabilities, showcasing the dual breakthroughs of startups in both technological innovation and commercial value.
The first Forbes China Investment Value Startup 100 Series Awards Ceremony will be held in Shanghai on April 17, 2025. At that time, Polyseq Biotechnology will share this moment of honor with other selected companies, and jointly look forward to the important role and broad prospects of startups in the future technological and industrial revolution.
